Sept 18 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS : * SUN PHARMACEUTICAL INDUSTRIES LTD - ALMIRALL GETS EUROPEAN COMMISSION APPROVAL FOR ILUMETRI
Following the sharp fall in stocks, the market capitalisation (m-cap) of BSE-listed companies dropped by ₹1,14,676.15 crore to ₹1,55,22,343 crore
Investing.com – India equities were lower at the close on Monday, as losses in the Consumer Durables, Fast Moving Consumer Goods and Carbon sectors propelled shares lower. At the...
Nifty witnessed massive short covering in today’s session ahead of the scheduled trading holiday tomorrow. Markets underwent high volatility as Put buyers continued to cover...
The Benchmark indices opened flat ahead of F&O August expiry with Sensex was up 1 point & Nifty below 11,700. The equity market traded lower as Sensex fell 35 points while...
Nifty launched a breakout rally of 92 points in today’s trading and made a high of 11700 approx. Today’s bull run was powered by PBOC’s decision to introduce a...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Strong Sell||Buy||Buy|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Sell||BUY|
|Summary||Strong Sell||Strong Sell||Strong Sell||Neutral||Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Abandoned Baby Bearish||1D||1||Sep 17, 2018|
|Evening Doji Star||1D||1||Sep 17, 2018|
|Doji Star Bearish||1M||2||Jul 18|
|Doji Star Bearish||1D||2||Sep 14, 2018|
|Three Outside Up||1D||2||Sep 14, 2018|
|Bank Of Baroda||113.10||126.45||111.85||-22.15||-16.38%||144.89M||15:59:20|
Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New Zealand and other markets. The Company offers its products to therapy areas, such as cardiology, neuro-psychiatry, gastroenterology, anti-infective, diabetology and dermatology. The Company's products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are situated in India, the United States and Brazil, among others. Its units produce generics, branded generics, specialty products, over-the-counter (OTC) products, anti-retroviral (ARVs) and APIs. They also produce intermediates in a range of dosage forms, including tablets, capsules, injectables, ointments, creams and liquids.Read More
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.